Market Cap (In INR)
37.5 Billion
Revenue (In INR)
5.82 Billion
Net Income (In INR)
876.6 Million
Avg. Volume
53.91 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1292.0-2974.95
- PE
- -
- EPS
- -
- Beta Value
- 0.433
- ISIN
- INE105J01010
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yugal Kishor Choturam Sikri
- Employee Count
- -
- Website
- https://www.rpglifesciences.com
- Ipo Date
- 2002-08-12
- Details
- RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
More Stocks
-
GOACARBONGoa Carbon Limited
GOACARBON
-
ESSITY-AEssity AB (publ)
ESSITY-A
-
THYROCAREThyrocare Technologies Limited
THYROCARE
-
UPLUPL Limited
UPL
-
9550
-
COFORGECoforge Limited
COFORGE
-
PRBProbe Gold Inc.
PRB
-
TBLT